Skip to main content
Journal cover image

No-carrier-added (4-fluoro-3-[131I]iodobenzyl)guanidine and (3-[211At]astato-4-fluorobenzyl)guanidine.

Publication ,  Journal Article
Vaidyanathan, G; Affleck, DJ; Zalutsky, MR
Published in: Bioconjug Chem
1996

With 3-bromo-4-fluorotoluene as starting material, [4-fluoro-3-(trimethylsilyl)benzyl]guanidine was prepared in five steps in 1.5% overall yield. Radioiodination of this silicon precursor using N-chlorosuccinimide in trifluoroacetic acid at room temperature for 5 min gave (4-fluoro-3-[131I]-iodobenzyl)guanidine ([131I]FIBG) in 50-60% radiochemical yield. A byproduct which had a retention time in two HPLC systems similar to that of (m-iodobenzyl)guanidine (MIBG) was formed in about 30% yield. [131I]FIBG was stable up to 3 h under these conditions of iodination, indicating that the byproduct is not generated as a result of [131I]FIBG degradation. Using hydrogen peroxide as the oxidant in aqueous medium and a reaction time of 30 min at 50 degrees C, yields of [131I]FIBG could be increased to 75-80%, with less than 7% of the byproduct formed under these conditions. Astatination of the silicon precursor using N-chlorosuccinimide in trifluoroacetic acid at 70 degrees C gave 65-70% radiochemical yield of (3-[211At]astato-4-fluorobenzyl)guanidine ([211At]AFBG) in 10-15 min; about 17% of the byproduct formation was seen. Astatination of the silicon precursor under aqueous conditions using hydrogen peroxide was not successful.

Duke Scholars

Published In

Bioconjug Chem

DOI

ISSN

1043-1802

Publication Date

1996

Volume

7

Issue

1

Start / End Page

102 / 107

Location

United States

Related Subject Headings

  • Tumor Cells, Cultured
  • Organic Chemistry
  • Neuroblastoma
  • Isotope Labeling
  • Iodobenzenes
  • Iodine Radioisotopes
  • Indicators and Reagents
  • Humans
  • Guanidines
  • Chromatography, High Pressure Liquid
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Vaidyanathan, G., Affleck, D. J., & Zalutsky, M. R. (1996). No-carrier-added (4-fluoro-3-[131I]iodobenzyl)guanidine and (3-[211At]astato-4-fluorobenzyl)guanidine. Bioconjug Chem, 7(1), 102–107. https://doi.org/10.1021/bc950078i
Vaidyanathan, G., D. J. Affleck, and M. R. Zalutsky. “No-carrier-added (4-fluoro-3-[131I]iodobenzyl)guanidine and (3-[211At]astato-4-fluorobenzyl)guanidine.Bioconjug Chem 7, no. 1 (1996): 102–7. https://doi.org/10.1021/bc950078i.
Vaidyanathan G, Affleck DJ, Zalutsky MR. No-carrier-added (4-fluoro-3-[131I]iodobenzyl)guanidine and (3-[211At]astato-4-fluorobenzyl)guanidine. Bioconjug Chem. 1996;7(1):102–7.
Vaidyanathan, G., et al. “No-carrier-added (4-fluoro-3-[131I]iodobenzyl)guanidine and (3-[211At]astato-4-fluorobenzyl)guanidine.Bioconjug Chem, vol. 7, no. 1, 1996, pp. 102–07. Pubmed, doi:10.1021/bc950078i.
Vaidyanathan G, Affleck DJ, Zalutsky MR. No-carrier-added (4-fluoro-3-[131I]iodobenzyl)guanidine and (3-[211At]astato-4-fluorobenzyl)guanidine. Bioconjug Chem. 1996;7(1):102–107.
Journal cover image

Published In

Bioconjug Chem

DOI

ISSN

1043-1802

Publication Date

1996

Volume

7

Issue

1

Start / End Page

102 / 107

Location

United States

Related Subject Headings

  • Tumor Cells, Cultured
  • Organic Chemistry
  • Neuroblastoma
  • Isotope Labeling
  • Iodobenzenes
  • Iodine Radioisotopes
  • Indicators and Reagents
  • Humans
  • Guanidines
  • Chromatography, High Pressure Liquid